[HTML][HTML] Clinical outcomes of prolonged infusion (extended infusion or continuous infusion) versus intermittent bolus of meropenem in severe infection: A meta …

Z Yu, X Pang, X Wu, C Shan, S Jiang - PloS one, 2018 - journals.plos.org
Background Meropenem exhibits time-dependent antimicrobial activity and prolonged
infusion (PI)(extended infusion or continuous infusion, EI or CI) of meropenem can better …

Optimizing β-lactams treatment in critically-ill patients using pharmacokinetics/pharmacodynamics targets: are first conventional doses effective?

IK Delattre, FS Taccone, F Jacobs, M Hites… - Expert review of anti …, 2017 - Taylor & Francis
Introduction: The pharmacokinetic/pharmacodynamic index determining β-lactam activity is
the percentage of the dosing interval (% T) during which their free serum concentration …

Pharmacokinetic/pharmacodynamic considerations for the optimization of antimicrobial delivery in the critically ill

D Tsai, J Lipman, JA Roberts - Current opinion in critical care, 2015 - journals.lww.com
Optimization of antimicrobial dosing in accordance with pharmacokinetics/
pharmacodynamics targets can improve survival and clinical cure. Dosing regimens for …

Population pharmacokinetics and evaluation of the predictive performance of pharmacokinetic models in critically ill patients receiving continuous infusion …

SAM Dhaese, A Farkas, P Colin… - Journal of …, 2019 - academic.oup.com
Abstract Background Several population pharmacokinetic (PopPK) models for meropenem
dosing in ICU patients are available. It is not known to what extent these models can predict …

[HTML][HTML] Population pharmacokinetics analysis and dosing simulations of meropenem in critically ill patients with pulmonary infection

J Lan, Z Wu, X Wang, Y Wang, F Yao, B Zhao… - Journal of …, 2022 - Elsevier
Purpose This study aimed to develop a population pharmacokinetic (PPK) model for
meropenem to optimize dosing regimens for critically ill patients with pulmonary infection …

Optimising meropenem dosing in critically ill Australian Indigenous patients with severe sepsis

D Tsai, P Stewart, R Goud, S Gourley… - International journal of …, 2016 - Elsevier
Currently there are no pharmacokinetic (PK) data to guide antibiotic dosing in critically ill
Australian Indigenous patients with severe sepsis. This study aimed to determine whether …

Optimal infusion rate in antimicrobial therapy: explosion of evidence in the last five years

L Zhu, Q Zhou - Infection and drug resistance, 2018 - Taylor & Francis
Background: Sporadic studies in antimicrobial therapy have evaluated the effects of infusion
rates on therapeutic and economic outcomes, and new findings may challenge the regular …

Scaling beta‐lactam antimicrobial pharmacokinetics from early life to old age

DO Lonsdale, EH Baker, K Kipper… - British journal of …, 2019 - Wiley Online Library
Aims Beta‐lactam dose optimization in critical care is a current priority. We aimed to review
the pharmacokinetics (PK) of three commonly used beta‐lactams (amoxicillin±clavulanate …

Selection of piperacillin/tazobactam infusion mode guided by SOFA score in cancer patients with hospital-acquired pneumonia: a randomized controlled study

Y Lyu, Y Yang, X Li, M Peng, X He… - … and clinical risk …, 2017 - Taylor & Francis
Background This study aimed to select piperacillin/tazobactam (TZP) infusion mode guided
by Sequential Organ Failure Assessment (SOFA) score in cancer patients with hospital …

Paradoxical antibiotic effect of ampicillin: use of a population pharmacokinetic model to evaluate a clinical correlate of the eagle effect in infants with bacteremia

JE Ericson, CP Hornik, RG Greenberg… - The Pediatric …, 2020 - journals.lww.com
Background: High doses of ampicillin are often used to achieve therapeutic drug
concentrations in infants. A paradoxical antibiotic effect, often called the Eagle effect, occurs …